ClementS., BraithwaiteS.S., MageeM.F.Management of diabetes and hyperglycemia in hospitals. Diabetes Care.2004; 27: 553–591.
2.
WheatL.Infection and diabetes mellitus. Diabetes Care.1980; 3: 187–197.
3.
The Expert Committee on the diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care.2003; 26(Suppl 1): S5–S20.
4.
JencksS.F.Accuracy in recorded diagnoses. JAMA1992; 267: 2238–2239.
NorhammarA., TenerzA., NilssonG.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet.2002; 359: 2140–2144.
7.
GreciL.S., KailasamM., MalkaniS.Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care.2003; 26: 1064–1068.
8.
AubertR., GeissL., BallardD.Diabetes-Related Hospitalization and Hospital Utilization.2nd ed.Bethesda, MD: National Institutes of Health; 1995: 555–556.
9.
JoshiN., CaputoG., WeitekampM., KarchmerA.Infections in patients with diabetes mellitus. N Engl J Med.1999; 341: 1906–1912.
10.
MowatA., BaumJ.Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med.1971; 284: 621–627.
11.
BagdadeJ., RootR., BulgerR.Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes.1974; 23: 9–15.
12.
BagdadeJ.D., StewartM., WaltersE.Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes.1978; 27: 677–681.
13.
van OssC.J., BorderJ.R.Influence of intermittent hyperglycemic glucose levels on the phagocytosis of microorganisms by human granulocytes in vitro. Immunol Commun.1978; 7: 669–676.
14.
DavidsonN., SowdenJ., FletcherJ.Defective phagocytosis in insulin-controlled diabetics: evidence for a reaction between glucose and opsonizing proteins. J Clin Pathol.1984; 37: 783–786.
15.
AlexiewiczJ., KumarD., SmogorzewskiM.Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med.1995; 123: 919–924.
16.
LeiboviciL., YehezkelliY., PorterA.Influence of diabetes mellitus and glycemic control on the characteristics and outcome of common infections. Diabet Med.1996; 13: 457–463.
17.
KwounM., LingP., LydonE.Immunologic effects of acute hyperglycemia in nondiabetic rats. J Parenter Enteral Nutr.1997; 21: 91–95.
18.
McManusL., BloodworthR., PrihodaT.Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol.2001; 70: 395–404.
19.
MarfellaR., NappoF., AngelisL.D.Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care.2000; 23: 658–663.
20.
MarfellaR., NappoF., AngelisL.D.The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia.2000; 43: 571–575.
21.
CinarY., SenyolA., DumanK.Blood viscosity and blood pressure: role of temperature and hyperglycemia. Am J Hypertens.2001; 14: 433–438.
22.
DaviG., CatalanoI., AvernaM.Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med.1990; 322: 1769–1774.
23.
KnoblerH., SavionN., ShenkmanB.Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res.1998; 90: 181–190.
24.
DaviG., CiabattoniG., ConsoliA.In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation.1999; 99: 224–229.
25.
SakamotoT., OgawaH., KawanoH.Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thrombosis & Hemostasis.2000; 83: 475–479.
26.
GreseleP., GuglielminiG., DeAngelisM.Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol.2003; 41: 1013–1020.
27.
BelcaroG., NicolaidesA.N., StansbyG., eds. The Venous Clinic.London: Imperial College Press, London; 1999.
28.
DeSanctisM.T., CesaroneM.R., IncandelaL.Methods of evaluation and quantification of microangiopathy in high perfusion microangiopathy (chronic venous insufficiency and diabetic microangiopathy). J Cardiovasc Pharmacol Ther.2002; 7(Suppl I): S3–S5.
29.
BelcaroG., NicolaidesA.N., eds. Noninvasive Investigations in Vascular Disease.London: Imperial College Press; 2001.
30.
AlmondN.E.A laser Doppler blood flowmeter used to detect thermal entrainment in normal persons and patients with Raynaud's phenomenon. In: SpenceV.A., SheldonC.D., eds. Practical Aspects of Skin Blood Flow Measurement.London: Biological Engineering Society; 1985: 45–54.
31.
AnningS.T.The cause and treatment of leg ulcers. Lancet.1952; ii: 789–791.
32.
AnningS.T.Leg ulcers. Their Causes and Treatment.London: J & A Churchill Ltd; 1954.
33.
AnningS.T.The historical aspect. In: DoddH., CockettF.B., eds. The Pathology and Surgery of the Veins of the Lower Limb.Edinburgh: Churchill-Livingstone; 1976: 34–43.
34.
BelcaroG.The role of transcutaneous PCO2 measurements in association with laser Doppler flowmetry in venous hypertension. Phlebology.1988; 3: 189–193.
35.
BelcaroG., GriggM., RuloA., NicolaidesA.N.Blood flow in the perimalleolar skin in relation to posture in patients with venous hypertension. Ann Vasc Surg.1989; 1: 5–8.
36.
BelcaroG., ChristopoulosD., NicolaidesA.N.Skin flow and swelling in postphlebitic limbs. Vasa.1989; 18: 136–138.
37.
BelcaroG., NicolaidesA.N., VolteasN.Skin flow, the venoartriolar response and capillary filtration in diabetics. A three-year follow-up study. Angiology1992; 43: 490–494.
FagrellB.Local microcirculation in chronic venous incompetence and leg ulcers. Vasc Surg.1979; 13: 217–219.
40.
FagrellB.Microcirculatory disturbances—the final cause for venous leg ulcers?Vasa.1982; 11: 101–103.
41.
FranzeckU., BollingerA., HuchR.Transcutaneous oxygen tension and capillary morphologic characteristics and density in patients with chronic venous incompetence. Circulation.1984; 70: 806–809.
42.
HendricksonO.Local reflex in microcirculation in human subcutaneous tissue. Acta Physiol Scand.1976; 97: 446–449.
43.
RaymanG., HassanA., TookeJ.E.Blood flow in the skin of the foot related to posture in patients with diabetes mellitus. BMJ.1986; 292: 87–91.
44.
ThulesiusO.Capillary filtration under normal and pathological conditions. Angiologia.1973; 10: 198–201.
45.
AbbottC.A., VileikyteL., WilliamsonS.Multicenter study of the incidence and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care.1998; 21: 1071–1075.
46.
StansberryK.B., PeppardH.R., BabyakL.M.Primary nociceptive afferents mediate the blood flow dysfunction in nonglabrous (hairy) skin of type 2 diabetes. Diabetes Care.1999; 22: 1549–1554.
47.
FromyB., AbrahamP., SaumetJ.L.Non-nociceptive capsaicin sensitive nerve terminal stimulation allows for an original vasodilatory reflex in the human skin. Brain Res.1998; 811: 166–168.
48.
AbrahamP., FromyB., MerzeauS.Dynamics of local pressure-induced cutaneous vasodilation in the human hand. Microvasc Res.2001; 61: 122–129.
49.
FromyB., AbrahamP., BouvetC.Early decrease of skin blood flow in response to locally applied pressure in diabetics. Diabetes.2002; 51: 1214–1217.
50.
PergolaP.E., KelloggD.L.Jr., JohnsonJ.M.Reflex control of active cutaneous vasodilation by skin temperature in humans. Am J Physiol.1994; 266: H1979–H1984.
51.
MitchellW.S., WinocourP.H., GushR.J.Skin blood flow and limited joint mobility in insulin-dependent diabetes mellitus. Br J Rheumatol.1989; 28: 195–200.
52.
SinghN., ArmstrongD.G., LipskyB.A.Preventing foot ulcers in patients with diabetes. JAMA.2005; 293: 217–228.
53.
BoweringC.K.Diabetic foot ulcers. Pathophysiology, assessment and therapy. Can Fam Physician.2001; 47: 1007–1016.
54.
BongiovanniC.M.Superoxidized water improves wound care outcomes in diabetic patients. Diabetic Microvasc Complications Today.2006; 3: 11–14.
NapoliB., ArpaN., IaiaA.Antibiotic salicylate Vaseline: A topical treatment of choice in burned diabetic patients?Ann Burn and Fire Disasters1999; 12: 146–150.
58.
AltamiranoA.M.Reducing bacterial infectious complications from burn wounds. Wounds.2006; 18: 17–19.
59.
ShalomA., FriedmanT., WongL.Burns and diabetes. Ann Burn and Fire Disasters.2005; 18: 31–37.
60.
PageJ.C., NewswanderB., SchwenkeD.C.Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care.2004; 17: 354–364.